vs

Side-by-side financial comparison of CuriosityStream Inc. (CURI) and TRANSACT TECHNOLOGIES INC (TACT). Click either name above to swap in a different company.

CuriosityStream Inc. is the larger business by last-quarter revenue ($19.2M vs $11.5M, roughly 1.7× TRANSACT TECHNOLOGIES INC). On growth, CuriosityStream Inc. posted the faster year-over-year revenue change (35.8% vs 11.9%). CuriosityStream Inc. produced more free cash flow last quarter ($3.9M vs $589.0K). Over the past eight quarters, CuriosityStream Inc.'s revenue compounded faster (26.5% CAGR vs 3.5%).

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

Roper Technologies, Inc. is a holding company that owns companies in the technology sector.

CURI vs TACT — Head-to-Head

Bigger by revenue
CURI
CURI
1.7× larger
CURI
$19.2M
$11.5M
TACT
Growing faster (revenue YoY)
CURI
CURI
+23.9% gap
CURI
35.8%
11.9%
TACT
More free cash flow
CURI
CURI
$3.4M more FCF
CURI
$3.9M
$589.0K
TACT
Faster 2-yr revenue CAGR
CURI
CURI
Annualised
CURI
26.5%
3.5%
TACT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CURI
CURI
TACT
TACT
Revenue
$19.2M
$11.5M
Net Profit
$-3.8M
Gross Margin
47.6%
Operating Margin
-17.6%
-10.1%
Net Margin
-19.7%
Revenue YoY
35.8%
11.9%
Net Profit YoY
-34.6%
EPS (diluted)
$-0.07
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CURI
CURI
TACT
TACT
Q4 25
$19.2M
$11.5M
Q3 25
$18.4M
$13.2M
Q2 25
$19.0M
$13.8M
Q1 25
$15.1M
$13.1M
Q4 24
$14.1M
$10.2M
Q3 24
$12.6M
$10.9M
Q2 24
$12.4M
$11.6M
Q1 24
$12.0M
$10.7M
Net Profit
CURI
CURI
TACT
TACT
Q4 25
$-3.8M
Q3 25
$-3.7M
$15.0K
Q2 25
$784.0K
$-143.0K
Q1 25
$319.0K
$19.0K
Q4 24
$-2.8M
Q3 24
$-3.1M
$-551.0K
Q2 24
$-2.0M
$-319.0K
Q1 24
$-5.0M
$-1.0M
Gross Margin
CURI
CURI
TACT
TACT
Q4 25
47.6%
Q3 25
49.8%
Q2 25
48.2%
Q1 25
48.7%
Q4 24
44.2%
Q3 24
48.1%
Q2 24
52.7%
Q1 24
52.6%
Operating Margin
CURI
CURI
TACT
TACT
Q4 25
-17.6%
-10.1%
Q3 25
-24.5%
0.1%
Q2 25
2.5%
-1.9%
Q1 25
0.5%
-0.1%
Q4 24
-27.4%
-10.3%
Q3 24
-25.8%
-7.7%
Q2 24
-20.6%
-3.8%
Q1 24
-30.4%
-12.2%
Net Margin
CURI
CURI
TACT
TACT
Q4 25
-19.7%
Q3 25
-20.4%
0.1%
Q2 25
4.1%
-1.0%
Q1 25
2.1%
0.1%
Q4 24
-19.9%
Q3 24
-24.3%
-5.1%
Q2 24
-16.4%
-2.8%
Q1 24
-42.0%
-9.7%
EPS (diluted)
CURI
CURI
TACT
TACT
Q4 25
$-0.07
$-0.11
Q3 25
$-0.06
$0.00
Q2 25
$0.01
$-0.01
Q1 25
$0.01
$0.00
Q4 24
$-0.05
$-0.80
Q3 24
$-0.06
$-0.06
Q2 24
$-0.04
$-0.03
Q1 24
$-0.09
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CURI
CURI
TACT
TACT
Cash + ST InvestmentsLiquidity on hand
$27.3M
$20.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$41.5M
$31.1M
Total Assets
$75.7M
$44.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CURI
CURI
TACT
TACT
Q4 25
$27.3M
$20.4M
Q3 25
$27.8M
$20.0M
Q2 25
$28.1M
$17.7M
Q1 25
$33.4M
$14.2M
Q4 24
$32.1M
$14.4M
Q3 24
$33.2M
$11.3M
Q2 24
$39.5M
$11.1M
Q1 24
$38.8M
$10.6M
Stockholders' Equity
CURI
CURI
TACT
TACT
Q4 25
$41.5M
$31.1M
Q3 25
$47.2M
$31.8M
Q2 25
$49.8M
$31.3M
Q1 25
$58.1M
$30.9M
Q4 24
$57.8M
$30.6M
Q3 24
$62.2M
$38.4M
Q2 24
$64.8M
$38.5M
Q1 24
$67.0M
$38.6M
Total Assets
CURI
CURI
TACT
TACT
Q4 25
$75.7M
$44.8M
Q3 25
$74.7M
$45.0M
Q2 25
$78.7M
$44.5M
Q1 25
$85.3M
$44.2M
Q4 24
$86.2M
$44.0M
Q3 24
$87.6M
$50.5M
Q2 24
$90.9M
$50.4M
Q1 24
$94.6M
$51.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CURI
CURI
TACT
TACT
Operating Cash FlowLast quarter
$4.0M
$609.0K
Free Cash FlowOCF − Capex
$3.9M
$589.0K
FCF MarginFCF / Revenue
20.5%
5.1%
Capex IntensityCapex / Revenue
0.1%
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$7.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CURI
CURI
TACT
TACT
Q4 25
$4.0M
$609.0K
Q3 25
$4.4M
$3.6M
Q2 25
$2.8M
$3.6M
Q1 25
$1.9M
$-161.0K
Q4 24
$3.0M
$2.4M
Q3 24
$2.3M
$327.0K
Q2 24
$2.2M
$636.0K
Q1 24
$666.0K
$-1.5M
Free Cash Flow
CURI
CURI
TACT
TACT
Q4 25
$3.9M
$589.0K
Q3 25
$3.6M
Q2 25
$3.6M
Q1 25
$1.8M
$-171.0K
Q4 24
$2.4M
Q3 24
$259.0K
Q2 24
$499.0K
Q1 24
$-1.6M
FCF Margin
CURI
CURI
TACT
TACT
Q4 25
20.5%
5.1%
Q3 25
27.1%
Q2 25
25.9%
Q1 25
12.2%
-1.3%
Q4 24
23.2%
Q3 24
2.4%
Q2 24
4.3%
Q1 24
-14.9%
Capex Intensity
CURI
CURI
TACT
TACT
Q4 25
0.1%
0.2%
Q3 25
0.0%
0.5%
Q2 25
0.0%
0.1%
Q1 25
0.5%
0.1%
Q4 24
0.0%
0.1%
Q3 24
0.0%
0.6%
Q2 24
0.0%
1.2%
Q1 24
0.0%
1.0%
Cash Conversion
CURI
CURI
TACT
TACT
Q4 25
Q3 25
242.00×
Q2 25
3.56×
Q1 25
6.03×
-8.47×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons